Compounding pharmacies are a critical, but often overlooked part of the healthcare continuum. Because of their direct impact on patient care, quality and safety are essential throughout these facilities.
Testing and quality standards for US facilities are addressed by the United States Pharmacopeial Convention; USP <797> provides guidelines for facilities in which compounded sterile preparations are prepared, stored and dispensed.
Sterility testing, media fill and monitoring of compounding environments are measures that compounding facilities can utilize to ensure quality and minimize the risk of contamination.
MilliporeSigma has the products and expertise to help guide you through these processes, minimize risk and ensure you comply with USP 797.